Olanzapine Tablet, Orally Disintegrating
Product Images NDC 0527-3161

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olanzapine (NDC 0527-3161). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 10 mg, 30 tablets)

Package Label (Olanzapine orally disintegrating tablets 10 mg, 30 tablets)
Label for Olanzapine Orally Disintegrating Tablets, USP 10 mg, distributed by Lannett Company, Inc. The label includes storage instructions, phenylalanine content, and manufacturing information by Sunshine Lake Pharma Co., Ltd. The package contains 30 tablets, with a barcode and reference to accompanying medication guide.*
FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 15 mg, 30 tablets)

Package Label (Olanzapine orally disintegrating tablets 15 mg, 30 tablets)
Label for Olanzapine Orally Disintegrating Tablets USP, 15 mg strength, containing 30 tablets. Distributed by Lannett Company, Inc., the label includes storage instructions, phenylalanine content warning, and manufacturing information by Sunshine Lake Pharma Co., Ltd., China. The label features the Lannett logo and a barcode.*
FDA Label Image

Package Label (Olanzapine orally disintegrating tablets 20 mg, 30 tablets)

Package Label (Olanzapine orally disintegrating tablets 20 mg, 30 tablets)
Label for Olanzapine Orally Disintegrating Tablets, USP 20 mg, distributed by Lannett Company, Inc. The label indicates a package containing 30 tablets. It provides storage instructions (20° to 25°C) and notes the presence of phenylalanine 0.032 mg per tablet. Manufactured by Sunshine Lake Pharma Co., Ltd., Guangdong Province, China. Includes a barcode and revision date of 05/23.*
FDA Label Image

Package Label Front Panel (Olanzapine orally disintegrating tablets 5 mg, 30 tablets)

Package Label Front Panel (Olanzapine orally disintegrating tablets 5 mg, 30 tablets)
Label for Olanzapine Orally Disintegrating Tablets, USP 5 mg, 30 count. The label shows storage instructions, phenylalanine content, and distribution information. It is distributed by Lannett Company, Inc. and manufactured by Sunshine Lake Pharma Co., Ltd. The label includes an NDC number 0527-3161-32, a barcode, and a Lannett logo.*
FDA Label Image

Logo (Logo1)

FDA Label Image

Logo (Logo2)

FDA Label Image

Chemical Structure (Olanzapine Chemical Structure)

Chemical Structure (Olanzapine Chemical Structure)
Chemical structure diagram of the active ingredient Olanzapine, displaying its molecular framework with aromatic rings and heteroatoms including nitrogen and sulfur.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.